Our results also revealed a significant association of the PI3K/AKT/mTOR signaling pathway with aggressive Xp11.2 tRCC. This evidence concerns the gene AKT1 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.